(Press-News.org) Washington, DC — Molecules containing large chains of carbon and hydrogen--the building blocks of all life on Earth--have been the targets of missions to Mars from Viking to the present day. While these molecules have previously been found in meteorites from Mars, scientists have disagreed about how this organic carbon was formed and whether or not it came from Mars.
A new paper led by Carnegie's Andrew Steele provides strong evidence that this carbon did originate on Mars, although it is not biological. These findings give researchers insight into the chemical processes taking place on Mars and will help aid future quests for evidence of ancient or modern Martian life. The work is published May 24 in Science Express.
There has been little agreement among scientists about the origin of the large carbon macromolecules detected in Martian meteorites. Theories about their origin include contamination from Earth or other meteorites, the results of chemical reactions on Mars, or that they are the remnants of ancient Martian biological life.
Steele's team examined samples from 11 Martian meteorites whose ages span about 4.2 billion years of Martian history. They detected large carbon compounds in 10 of them. The molecules were found inside of grains of crystallized minerals.
Using an array of sophisticated research techniques, the team was able to show that at least some of the macromolecules of carbon were indigenous to the meteorites themselves and not contamination from Earth.
Next the team looked at the carbon molecules in relation to other minerals in the meteorites to see what kinds of chemical processing these samples endured before arriving on Earth. The crystalline grains encasing the carbon compounds provided a window into how the carbon molecules were created. Their findings indicate that the carbon was created during volcanism on Mars and show that Mars has been doing organic chemistry for most of its history.
"These findings show that the storage of reduced carbon molecules on Mars occurred throughout the planet's history and might have been similar to processes that occurred on the ancient Earth," Steele said. "Understanding the genesis of these non-biological, carbon-containing macromolecules on Mars is crucial for developing future missions to detect evidence of life on our neighboring planet."
In a separate paper published by American Mineralogist, available online, Steele and his team studied a meteorite called Allan Hills 84001 that was reported to contain relicts of ancient biological life on Mars. The paper demonstrated that these supposed remnants could have been created by chemical reactions involving the graphite form of carbon, rather than biological processes. Both of these papers reveal a pool of reduced carbon on Mars and will help scientist involved in future Mars missions distinguish these non-biologically formed molecules from potential life.
###The research for the Science Express paper was funded by NASA, the W.M. Keck Foundation, the Natural Science and Engineering Research Council of Canada, and the Carnegie Institution for Science. The research for the American Mineralogist paper was supported by NASA.
The Carnegie Institution for Science (carnegiescience.edu) is a private, nonprofit organization headquartered in Washington, D.C., with six research departments throughout the U.S. Since its founding in 1902, the Carnegie Institution has been a pioneering force in basic scientific research. Carnegie scientists are leaders in plant biology, developmental biology, astronomy, materials science, global ecology, and Earth and planetary science.
Organic carbon from Mars, but not biological
2012-05-28
ELSE PRESS RELEASES FROM THIS DATE:
Locating ground zero
2012-05-28
VIDEO:
Microglia (green) move to the site of injury (arrow) to clear up debris.
Click here for more information.
Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now discovered exactly how microglia detect the site of injury, ...
Gene therapy can correct forms of severe combined immunodeficiency
2012-05-28
Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene. Traditional treatment options, such as enzyme replacement therapy, are of limited efficacy, but bone marrow transplant from a compatible donor leads to a better response. A recent clinical trial indicated that gene therapy to insert the correct ADA gene in the patient's ...
A new strategy for developing meningitis vaccines
2012-05-28
Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain. Children, elderly patients and immunocompromised patients are at a higher risk for the development of severe bacterial meningitis. Recently, researchers at the University of Adelaide in Australia sought to identify new vaccine targets in Streptococcus pneumoniae, which is the most common cause of bacterial meningitis in the world. Led by Dr. Abiodun Ogunniyi, the research team developed a new method of screening for bacterial genes that are expressed during ...
Marked for destruction: Newly developed compound triggers cancer cell death
2012-05-28
The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic BCL-2 proteins. However, cancer cells respond to therapy by increasing expression of anti-apoptotic proteins, which bind and neutralize pro-apoptotic family members and mediate therapeutic resistance. Therefore, development of therapeutic strategies to neutralize resistance to apoptosis will be critical to clinical improvements.
A research group ...
JCI early table of contents for May 24, 2012
2012-05-28
GENE THERAPY
Gene therapy can correct forms of severe combined immunodeficiency
Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene. Traditional treatment options, such as enzyme replacement therapy, are of limited efficacy, but bone marrow transplant from a compatible donor leads to a better response. A recent clinical ...
A boost in microRNA may protect against sepsis and other inflammatory diseases
2012-05-28
BOSTON, MA—Acute inflammatory diseases, such as sepsis, as well as chronic inflammatory diseases like diabetes and arthritis, develop as a result of sustained inflammation of the blood vessel wall. Researchers at Brigham and Women's Hospital (BWH) have discovered that a microRNA (small, non-coding RNA molecule) called miR-181b can reduce the inflammatory response that is responsible for such diseases.
The findings, by researchers led by Mark Feinberg, MD from BWH and Harvard Medical School, will pave the way for new targets in the development of anti-inflammatory therapies. ...
Nuisance seaweed found to produce compounds with biomedical potential
2012-05-28
A seaweed considered a threat to the healthy growth of coral reefs in Hawaii may possess the ability to produce substances that could one day treat human diseases, a new study led by scientists at Scripps Institution of Oceanography at UC San Diego has revealed.
An analysis led by Hyukjae Choi, a postdoctoral researcher in William Gerwick's laboratory at Scripps, has shown that the seaweed, a tiny photosynthetic organism known as a "cyanobacterium," produces chemical compounds that exhibit promise as anti-inflammatory agents and in combatting bacterial infections. The ...
Chronic pain is relieved by cell transplantation in lab study
2012-05-28
Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.
The researchers, working with mice, focused on treating chronic pain that arises from nerve injury -- so-called neuropathic pain.
In their study, published in the March 24, 2012 issue of Neuron, the scientists transplanted immature embryonic nerve cells that arise in the brain during development and ...
Gourmet butterflies speed north
2012-05-28
A new study led by scientists in the Department of Biology at the University of York has shown how a butterfly has changed its diet, and consequently has sped northwards in response to climate change.
Their study is published in the latest issue of Science.
The researchers found that warmer summers have allowed the Brown Argus butterfly to complete its life cycle by eating wild Geranium plants. Because the Geraniums are widespread in the British countryside, this change in diet has allowed the butterfly to expand its range in Britain at a surprisingly rapid rate. Over ...
The cells' petrol pump is finally identified
2012-05-28
Our cells breathe and digest, as does the organism as a whole. They indeed use oxygen to draw the energy contained in the nutrients they ingest, before discarding the waste, as carbon dioxide and water. Glucose is a preferred nutrient for the cells. Its digestion occurs in the cytoplasm, in the absence of oxygen, and leads to the formation of pyruvate and a small amount of energy. Pyruvate is then carried into mitochondria, the cell's power plants, for a complete burning, thus providing a maximal energetic yield.
A mediocre energetic yield in tumor cells
'As opposed ...